326 related articles for article (PubMed ID: 18070707)
1. Genetic events in the pathogenesis of multiple myeloma.
Chng WJ; Glebov O; Bergsagel PL; Kuehl WM
Best Pract Res Clin Haematol; 2007 Dec; 20(4):571-96. PubMed ID: 18070707
[TBL] [Abstract][Full Text] [Related]
2. [Study of the etiologic pathogenesis of multiple myeloma].
Hou J; Kong X
Zhonghua Xue Ye Xue Za Zhi; 1998 Nov; 19(11):607-9. PubMed ID: 11263345
[No Abstract] [Full Text] [Related]
3. Role of genetics in prognostication in myeloma.
Avet-Loiseau H
Best Pract Res Clin Haematol; 2007 Dec; 20(4):625-35. PubMed ID: 18070710
[TBL] [Abstract][Full Text] [Related]
4. [Subclassification of multiple myeloma based on the partner genes of immunoglobulin heavy chain gene translocations].
Nishida K; Taniwaki M
Rinsho Ketsueki; 2000 May; 41(5):414-7. PubMed ID: 10879102
[No Abstract] [Full Text] [Related]
5. Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study.
D'Souza A; Pasquini M; Logan B; Giralt S; Krishnan A; Antin J; Howard A; Goodman S; Qazilbash M; Knust K; Sahebi F; Weisdorf D; Vesole D; Stadtmauer E; Maloney D; Hari P
Br J Haematol; 2017 Sep; 178(5):816-819. PubMed ID: 27292583
[No Abstract] [Full Text] [Related]
6. MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management.
Rajkumar SV
Hematology Am Soc Hematol Educ Program; 2005; ():340-5. PubMed ID: 16304401
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
Lee JW; Lee JK; Hong YJ; Hong SI; Chang YH
Korean J Lab Med; 2008 Dec; 28(6):413-8. PubMed ID: 19127104
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the immunoglobulin code in multiple myeloma.
Szczepanski T
Haematologica; 2006 Jun; 91(6):725B. PubMed ID: 16769570
[No Abstract] [Full Text] [Related]
9. Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients.
Medina A; Jiménez C; Sarasquete ME; González M; Chillón MC; Balanzategui A; Prieto-Conde I; García-Álvarez M; Puig N; González-Calle V; Alcoceba M; Cuenca I; Barrio S; Escalante F; Gutiérrez NC; Gironella M; Hernández MT; Sureda A; Oriol A; Bladé J; Lahuerta JJ; San Miguel JF; Mateos MV; Martínez-López J; Calasanz MJ; García-Sanz R
Blood Cancer J; 2020 Feb; 10(2):14. PubMed ID: 32029700
[TBL] [Abstract][Full Text] [Related]
10. Molecular aspects of multiple myeloma.
Pratt G
Mol Pathol; 2002 Oct; 55(5):273-83. PubMed ID: 12354927
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma.
Mattioli M; Agnelli L; Fabris S; Baldini L; Morabito F; Bicciato S; Verdelli D; Intini D; Nobili L; Cro L; Pruneri G; Callea V; Stelitano C; Maiolo AT; Lombardi L; Neri A
Oncogene; 2005 Apr; 24(15):2461-73. PubMed ID: 15735737
[TBL] [Abstract][Full Text] [Related]
12. Chromosomal and genetic abnormalities in myeloma.
Joy Ho P
Clin Lab Haematol; 2002 Oct; 24(5):259-69. PubMed ID: 12358886
[TBL] [Abstract][Full Text] [Related]
13. T-cell-epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma.
Fagerberg J; Yi Q; Gigliotti D; Harmenberg U; Rudén U; Persson B; Osterborg A; Mellstedt H
Int J Cancer; 1999 Mar; 80(5):671-80. PubMed ID: 10048965
[TBL] [Abstract][Full Text] [Related]
14. V. Molecular classification and risk stratification of myeloma.
Bergsagel PL; Chesi M
Hematol Oncol; 2013 Jun; 31 Suppl 1(0 1):38-41. PubMed ID: 23775647
[No Abstract] [Full Text] [Related]
15. Genetics and cytogenetics of multiple myeloma: a workshop report.
Fonseca R; Barlogie B; Bataille R; Bastard C; Bergsagel PL; Chesi M; Davies FE; Drach J; Greipp PR; Kirsch IR; Kuehl WM; Hernandez JM; Minvielle S; Pilarski LM; Shaughnessy JD; Stewart AK; Avet-Loiseau H
Cancer Res; 2004 Feb; 64(4):1546-58. PubMed ID: 14989251
[TBL] [Abstract][Full Text] [Related]
16. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.
Shou Y; Martelli ML; Gabrea A; Qi Y; Brents LA; Roschke A; Dewald G; Kirsch IR; Bergsagel PL; Kuehl WM
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):228-33. PubMed ID: 10618400
[TBL] [Abstract][Full Text] [Related]
17. A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR.
Kaiser MF; Walker BA; Hockley SL; Begum DB; Wardell CP; Gonzalez D; Ross FM; Davies FE; Morgan GJ
Leukemia; 2013 Aug; 27(8):1754-7. PubMed ID: 23318961
[No Abstract] [Full Text] [Related]
18. Understanding the molecular biology of myeloma and its therapeutic implications.
Boyd KD; Pawlyn C; Morgan GJ; Davies FE
Expert Rev Hematol; 2012 Dec; 5(6):603-17. PubMed ID: 23216592
[TBL] [Abstract][Full Text] [Related]
19. Genetics of multiple myeloma.
Higgins MJ; Fonseca R
Best Pract Res Clin Haematol; 2005; 18(4):525-36. PubMed ID: 16026735
[TBL] [Abstract][Full Text] [Related]
20. Early genetic events provide the basis for a clinical classification of multiple myeloma.
Kuehl WM; Bergsagel PL
Hematology Am Soc Hematol Educ Program; 2005; ():346-52. PubMed ID: 16304402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
